Back

News

Learn more about our company, latest developments in clinical diagnostics, and scientific breakthroughs in the rare disease field. Stay on top, subscribe to our newsletter and follow us on social media.

  1. News

News


Accelerating new rare disease therapies through collaboration agreement


Global award honors entrepreneurship, innovation, and personal commitment


Supporting rare disease diagnosis, education, and clinical research


Driving Accelerated Diagnosis and Treatment Development


Driving personalized, immune-based therapy to target patients’ own immune responses


CENTOGENE biomarker measures lyso-Gb1 levels in children


Variant Prioritization Tool Driven by World’s Largest Curated Mutation Database


Artificial Intelligence verbessert die Diagnose seltener Erkrankungen, basierend auf der weltweit größten kuratierten...


Research findings may provide deeper understanding on the role of genes that can contribute to development of...


In a whitepaper released today, CENTOGENE provided an update on its induced pluripotent stem cells (iPSC) program.